Cradle is a cryonics company that develops and proves the feasibility of human organs and whole-body reversible cryopreservation.
Cradle has raised $48.0M in total funding. The most recent round was Series A. The last funding was announced in June 2024.
Cradle is headquartered in San Francisco, United States.
Cradle is a cryonics company that develops and proves the feasibility of human organs and whole-body reversible cryopreservation.
Cradle is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Cradle — Funding & Investors." VCBacked, June 6, 2024, https://www.vcbacked.co/company/cradle. Accessed July 19, 2026.
VCBacked. (2024). Cradle — Funding & Investors. Retrieved July 19, 2026, from https://www.vcbacked.co/company/cradle
{{cite web |title=Cradle — Funding & Investors |url=https://www.vcbacked.co/company/cradle |website=VCBacked |access-date=July 19, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated